Published in Pediatr Transplant on August 01, 2005
Neurologic and ophthalmologic complications of vascular access in a hemodialysis patient. Pediatr Nephrol (2007) 0.87
Intracranial hypertension: An unusual presentation of mucormycosis in a kidney transplant recipient. Indian J Nephrol (2013) 0.75
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol (2008) 8.79
Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (2007) 8.68
Transcranial direct current stimulation: State of the art 2008. Brain Stimul (2008) 6.81
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med (2006) 6.17
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant (2005) 2.70
Pathophysiology of persistent syringomyelia after decompressive craniocervical surgery. Clinical article. J Neurosurg Spine (2010) 2.49
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation (2003) 2.48
Reward improves long-term retention of a motor memory through induction of offline memory gains. Curr Biol (2011) 2.35
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood (2004) 2.27
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation (2014) 2.26
Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms? Hum Mutat (2009) 2.25
Neurofibromatosis type 2. Lancet (2009) 2.24
Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation (2006) 2.24
Composite tissue allotransplantation: development of a preclinical model in nonhuman primates. Transplantation (2005) 2.08
Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain (2005) 2.03
Transcranial direct current stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (2010) 1.93
Pathophysiology of primary spinal syringomyelia. J Neurosurg Spine (2012) 1.92
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis. Brain (2009) 1.91
Focal brain damage protects against post-traumatic stress disorder in combat veterans. Nat Neurosci (2007) 1.82
Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg (2002) 1.79
Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet (2002) 1.76
Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. Nat Med (2009) 1.76
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation (2016) 1.68
User-friendly software for the analysis of brain lesions (ABLe). Comput Methods Programs Biomed (2007) 1.63
Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation (2006) 1.61
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD. BMC Neurol (2006) 1.60
The impact of renal function on outcomes of bariatric surgery. J Am Soc Nephrol (2012) 1.60
Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors. J Neurosurg (2012) 1.59
Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment. J Neurosurg (2006) 1.55
Quantification of brain lesions using interactive automated software. Behav Res Methods Instrum Comput (2002) 1.51
West Nile virus: pathogenesis and therapeutic options. Ann Intern Med (2004) 1.51
Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation. Transplantation (2011) 1.51
Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg (2007) 1.51
The vestibular aqueduct: site of origin of endolymphatic sac tumors. J Neurosurg (2008) 1.49
Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant (2002) 1.48
Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med (2002) 1.47
Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol (2003) 1.44
Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in von Hippel-Lindau disease. Otol Neurotol (2007) 1.41
LFA-1-specific therapy prolongs allograft survival in rhesus macaques. J Clin Invest (2010) 1.41
Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes. Arthritis Rheum (2012) 1.40
Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation (2005) 1.40
Corticobasal syndrome associated with the A9D Progranulin mutation. J Neuropathol Exp Neurol (2007) 1.39
Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med (2004) 1.38
Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J Immunol (2010) 1.38
Single-trial fMRI shows contralesional activity linked to overt naming errors in chronic aphasic patients. J Cogn Neurosci (2010) 1.38
Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology (2003) 1.36
Priming stimulation enhances the depressant effect of low-frequency repetitive transcranial magnetic stimulation. J Neurosci (2003) 1.36
Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol (2006) 1.35
Physiological and modeling evidence for focal transcranial electrical brain stimulation in humans: a basis for high-definition tDCS. Neuroimage (2013) 1.34
Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. Neoplasia (2007) 1.33
Successful treatment of melanoma brain metastases with adoptive cell therapy. Clin Cancer Res (2010) 1.31
Surgery versus watchful waiting in patients with craniofacial fibrous dysplasia--a meta-analysis. PLoS One (2011) 1.27
TDCS guided using fMRI significantly accelerates learning to identify concealed objects. Neuroimage (2010) 1.27
Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord (2006) 1.26
Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant (2005) 1.25
Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery (2006) 1.23
Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome. Biol Psychiatry (2005) 1.23
Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol (2005) 1.23
Characteristics of frontotemporal dementia patients with a Progranulin mutation. Ann Neurol (2006) 1.22
Effect of donor factors on early graft survival in adult cadaveric renal transplantation. Am J Transplant (2002) 1.19
Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Mov Disord (2004) 1.18
A psychological and neuroanatomical model of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci (2008) 1.18
Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg (2005) 1.17
Effect of ependymal and pial surfaces on convection-enhanced delivery. J Neurosurg (2008) 1.17
Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro Oncol (2009) 1.17
Image-guided convection-enhanced delivery of gemcitabine to the brainstem. J Neurosurg (2007) 1.17
Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings. AJR Am J Roentgenol (2002) 1.17
Electroconvulsive therapy and repetitive transcranial magnetic stimulation in children and adolescents: a review and report of two cases of epilepsia partialis continua. Child Adolesc Psychiatr Clin N Am (2005) 1.17
White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain (2011) 1.15
Effects of ovarian hormones on human cortical excitability. Ann Neurol (2002) 1.14
Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation (2002) 1.14
Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One (2012) 1.13
Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment. J Neurosurg (2005) 1.13
IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am J Transplant (2005) 1.13
Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess. J Clin Endocrinol Metab (2012) 1.13
Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain (2006) 1.12
Consensus: Can transcranial direct current stimulation and transcranial magnetic stimulation enhance motor learning and memory formation? Brain Stimul (2008) 1.12
Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol (2008) 1.11
Effects of VHL deficiency on endolymphatic duct and sac. Cancer Res (2005) 1.11
Tolerability of transcranial direct current stimulation in childhood-onset schizophrenia. Brain Stimul (2011) 1.11
Induction immunosuppression. Transplantation (2006) 1.10
Pituitary stalk hemangioblastomas in von Hippel-Lindau disease. J Neurosurg (2009) 1.10
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma. Neuro Oncol (2011) 1.09
Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry (2003) 1.09
A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas. Neuro Oncol (2010) 1.08
Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest (2006) 1.08
PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. J Immunol (2008) 1.07
Functional connectivity between somatosensory and visual cortex in early blind humans. Eur J Neurosci (2004) 1.07
Should transcranial magnetic stimulation research in children be considered minimal risk? Clin Neurophysiol (2004) 1.05
Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging (2012) 1.05
Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease. Ann Neurol (2005) 1.05
Reward-related activity in the human motor cortex. Eur J Neurosci (2008) 1.05